NO20016344D0 - Nye polypeptider og deres DNA - Google Patents

Nye polypeptider og deres DNA

Info

Publication number
NO20016344D0
NO20016344D0 NO20016344A NO20016344A NO20016344D0 NO 20016344 D0 NO20016344 D0 NO 20016344D0 NO 20016344 A NO20016344 A NO 20016344A NO 20016344 A NO20016344 A NO 20016344A NO 20016344 D0 NO20016344 D0 NO 20016344D0
Authority
NO
Norway
Prior art keywords
polypeptides
salts
compounds
present
dna
Prior art date
Application number
NO20016344A
Other languages
English (en)
Other versions
NO20016344L (no
Inventor
Yasuaki Itoh
Kazunori Nishi
Kazuhiro Ogi
Shoichi Ohkubo
Shinichi Mogi
Yuko Noguchi
Koji Yoshimura
Hideyuki Tanaka
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO20016344D0 publication Critical patent/NO20016344D0/no
Publication of NO20016344L publication Critical patent/NO20016344L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20016344A 1999-06-30 2001-12-21 Nye polypeptider og deres DNA NO20016344L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18671899 1999-06-30
PCT/JP2000/004278 WO2001002564A1 (fr) 1999-06-30 2000-06-29 Nouveau polypeptide et adn de ce polypeptide

Publications (2)

Publication Number Publication Date
NO20016344D0 true NO20016344D0 (no) 2001-12-21
NO20016344L NO20016344L (no) 2002-02-19

Family

ID=16193433

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016344A NO20016344L (no) 1999-06-30 2001-12-21 Nye polypeptider og deres DNA

Country Status (12)

Country Link
US (1) US6797483B1 (no)
EP (1) EP1191099B1 (no)
KR (1) KR20020026465A (no)
CN (1) CN1359421A (no)
AT (1) ATE445013T1 (no)
AU (1) AU5705600A (no)
CA (1) CA2377791A1 (no)
DE (1) DE60043106D1 (no)
HU (1) HUP0201660A2 (no)
NO (1) NO20016344L (no)
PL (1) PL353065A1 (no)
WO (1) WO2001002564A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030166525A1 (en) 1998-07-23 2003-09-04 Hoffmann James Arthur FSH Formulation
AU2001232967A1 (en) * 2000-01-25 2001-08-07 Hyseq, Inc. Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides
WO2004013326A1 (en) * 2002-08-05 2004-02-12 Asahi Kasei Pharma Corporation Cartilage differentiation inhibiting gene
WO2004015078A2 (en) * 2002-08-08 2004-02-19 Nuvelo, Inc. Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides
KR101105486B1 (ko) 2003-04-02 2012-01-13 아레스 트레이딩 에스.에이. Ｆｓｈ 및 ｌｈ과 비이온성 계면활성제의 액상 약제학적 제제
ES2414705T3 (es) 2003-06-20 2013-07-22 Ares Trading S.A. Formulaciones liofilizadas de FSH/LH
CN108602866A (zh) * 2015-09-18 2018-09-28 生命制药有限责任公司 通过使用cd-rap前体蛋白改善cd-rap制备过程中的表达和折叠

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA945278B (en) * 1993-07-20 1996-01-19 Boehringer Mannheim Gmbh Melanoma-inhibiting protein
US6653445B1 (en) * 1997-01-21 2003-11-25 Human Genome Sciences, Inc. Human CCV polypeptides
AU1934999A (en) 1997-12-20 1999-07-12 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
WO2001048203A1 (fr) 1999-12-27 2001-07-05 Takeda Chemical Industries, Ltd. Nouvelle proteine et adn associe
AU2001232967A1 (en) 2000-01-25 2001-08-07 Hyseq, Inc. Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides
JP6623690B2 (ja) 2015-10-30 2019-12-25 味の素株式会社 グルタミン酸系ｌ−アミノ酸の製造法

Also Published As

Publication number Publication date
EP1191099A1 (en) 2002-03-27
CN1359421A (zh) 2002-07-17
CA2377791A1 (en) 2001-01-11
PL353065A1 (en) 2003-10-06
DE60043106D1 (de) 2009-11-19
EP1191099B1 (en) 2009-10-07
NO20016344L (no) 2002-02-19
KR20020026465A (ko) 2002-04-10
AU5705600A (en) 2001-01-22
ATE445013T1 (de) 2009-10-15
WO2001002564A1 (fr) 2001-01-11
US6797483B1 (en) 2004-09-28
HUP0201660A2 (en) 2002-08-28
EP1191099A4 (en) 2002-08-07

Similar Documents

Publication Publication Date Title
DE60207652D1 (de) Durch Säuregruppen disubstitierte Heteroaryl-Derivate und ihre Verwendung als Matrix Metalloproteinas Inhibitoren
DE60128916D1 (de) Neues, physiologisch aktives peptid und dessen verwendung
SE9903544D0 (sv) Novel compounds
NO20012966L (no) Kondenserte 1,2,4-tiadiazinderivater, deres fremstilling og anvendelse
DE602004029580D1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
ATE365213T1 (de) Aminosäuresequenzen die die fähigkeit besitzen, die durchdringung durch eine biologische barriere erleichtern
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
DK2157192T3 (da) Sammensætninger til diagnose og terapi af sygdomme forbundet med afvigende ekspression af futriner (R-spondiner)
NO20021542L (no) Nye <alfa>-aminosyresulfonylforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdendedem
BR0210358A (pt) Inibidores da protease de hiv, composições contendo os mesmos, seus usos farmacêuticos e materiais para sua sìntese
NO20022285L (no) Nye <alfa>-aminosyreforbindelser, fremgangsmÕte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
BR0314688A (pt) Novos derivados de piperidina para utilização no tratamento de estados de doença mediados pela quimiocina
DK15589D0 (da) Kemiske forbindelser
FR2848413B1 (fr) Plaque d'osteosynthese pour l'osteosynthese de petits os voisins les uns des autres
BR0213355A (pt) composições farmacêuticas
SE0301446D0 (sv) New Compounds
MA26608A1 (fr) Procede de preparation d'une composition pharmaceutique destinee au traitement de l'insuffisance cardiaque.
BR0016742A (pt) Compostos e composições antipicorna virais, suas aplicações farmacêuticas, e materiais para sua sìntese
SE9804212D0 (sv) Compounds
SG121733A1 (en) Nucleic acid molecules polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
NO20016344L (no) Nye polypeptider og deres DNA
BR0211635A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de um indivìduo sofrendo de ou propenso à doença de alzheimer
BR9811821A (pt) 2-acilaminopropanaminas como antagonistas de receptores de taquicinina
DK1196442T3 (da) VGF-polypeptider og fremgangsmåder til behandling af VGF-relaterede lidelser
DE60216457D1 (de) Carbamate verbindungen zur behandlung oder verhutung von psychotischen krankheiten

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application